CA 2024 * | 117 M 107 M | CA 2025 * | 130 M 119 M | Capitalisation | 78,78 M 71,87 M |
---|---|---|---|---|---|
Résultat net 2024 * | -11 M -10,04 M | Résultat net 2025 * | 1 M 912 k | VE / CA 2024 * | 0,67 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 0,61 x |
PER 2024 * |
-6,9
x | PER 2025 * |
166
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 98,37% |
Dernier transcript sur Depomed Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Heather Mason
CEO | Chief Executive Officer | 63 | 01/02/19 |
Ajay Patel
DFI | Director of Finance/CFO | 40 | 01/07/19 |
Howard Franklin
CTO | Chief Tech/Sci/R&D Officer | - | 06/03/23 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Peter Staple
CHM | Chairman | 72 | 01/11/03 |
James Tyree
BRD | Director/Board Member | 71 | 01/10/16 |
William McKee
BRD | Director/Board Member | 62 | 01/03/17 |
Varia. 1 janv. | Capi. | |
---|---|---|
+25,83% | 661 Md | |
+26,60% | 566 Md | |
-6,76% | 352 Md | |
+20,34% | 332 Md | |
+3,00% | 283 Md | |
+14,75% | 231 Md | |
+5,22% | 200 Md | |
-8,96% | 195 Md | |
-6,26% | 145 Md |